"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2014-2015

ABSTRACT

Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB. Detailed Description The investigators' aim is to prove that half dose sugammadex in combination with neostigmine 0.05 mg/kg is non-inferior to the recommended dose of sugammadex for the reversal of deep ( absence of Trian of Four response :TOF) or moderate ( TOF 1 or 2 twiches) muscle paralysis in patients undergoing surgery under general anesthesia. More... »

URL

https://clinicaltrials.gov/show/NCT02375217

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB.\n\nDetailed Description\nThe investigators' aim is to prove that half dose sugammadex in combination with neostigmine 0.05 mg/kg is non-inferior to the recommended dose of sugammadex for the reversal of deep ( absence of Trian of Four response :TOF) or moderate ( TOF 1 or 2 twiches) muscle paralysis in patients undergoing surgery under general anesthesia.", 
    "endDate": "2015-10-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT02375217", 
    "keywords": [
      "low dose", 
      "full dose", 
      "neuromuscular", 
      "cost saving", 
      "non-inferiority", 
      "trial", 
      "adult patient", 
      "elective surgery", 
      "patient", 
      "half", 
      "reversal", 
      "NMB", 
      "investigator aim", 
      "non-inferior", 
      "recommended dose", 
      "absence", 
      "ToF", 
      "muscle paralysis", 
      "General Surgery", 
      "general anesthesia"
    ], 
    "name": "\"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy\"", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT02375217"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00018.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.411654.3", 
        "type": "Organization"
      }
    ], 
    "startDate": "2014-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12871-017-0348-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084749670", 
          "https://doi.org/10.1186/s12871-017-0348-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12871-017-0348-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084749670", 
          "https://doi.org/10.1186/s12871-017-0348-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT02375217"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02375217'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02375217'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02375217'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02375217'


 

This table displays all metadata directly associated to this object as RDF triples.

43 TRIPLES      16 PREDICATES      36 URIs      29 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT02375217 schema:about anzsrc-for:3053
2 schema:description Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB. Detailed Description The investigators' aim is to prove that half dose sugammadex in combination with neostigmine 0.05 mg/kg is non-inferior to the recommended dose of sugammadex for the reversal of deep ( absence of Trian of Four response :TOF) or moderate ( TOF 1 or 2 twiches) muscle paralysis in patients undergoing surgery under general anesthesia.
3 schema:endDate 2015-10-01T00:00:00Z
4 schema:keywords General Surgery
5 NMB
6 ToF
7 absence
8 adult patient
9 cost saving
10 elective surgery
11 full dose
12 general anesthesia
13 half
14 investigator aim
15 low dose
16 muscle paralysis
17 neuromuscular
18 non-inferior
19 non-inferiority
20 patient
21 recommended dose
22 reversal
23 trial
24 schema:name "Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
25 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02375217
26 schema:sdDatePublished 2019-03-07T15:25
27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
28 schema:sdPublisher Nd8b8666adc434ee58466cc1ee4cea597
29 schema:sponsor https://www.grid.ac/institutes/grid.411654.3
30 schema:startDate 2014-10-01T00:00:00Z
31 schema:subjectOf sg:pub.10.1186/s12871-017-0348-9
32 schema:url https://clinicaltrials.gov/show/NCT02375217
33 sgo:license sg:explorer/license/
34 sgo:sdDataset clinical_trials
35 rdf:type schema:MedicalStudy
36 Nd8b8666adc434ee58466cc1ee4cea597 schema:name Springer Nature - SN SciGraph project
37 rdf:type schema:Organization
38 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
39 rdf:type schema:DefinedTerm
40 sg:pub.10.1186/s12871-017-0348-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084749670
41 https://doi.org/10.1186/s12871-017-0348-9
42 rdf:type schema:CreativeWork
43 https://www.grid.ac/institutes/grid.411654.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...